文献速递复苏、休克与脓毒症创伤与烧伤

创伤性出血的院前全血输注——一项随机对照试验

Prehospital Whole Blood in Traumatic Hemorrhage - A Randomized Controlled Trial.
PubMed 文献 · N Engl J Med · 2026-03-17
一句话结论严重创伤性出血患者院前输注最多2单位全血,在降低24小时内死亡或大量输血风险方面不优于标准成分血治疗。

这项在英格兰10家空中救护服务机构开展的实用性、3期、多中心、非盲、随机、优效性试验,纳入重大创伤性出血患者,随机接受院前全血输注(最多2单位)或标准成分血治疗(最多2单位红细胞和2单位血浆)。942例随机化后,排除非创伤性出血或创伤性心脏骤停者,616例纳入分析(全血组314例,标准组302例)。主要终点(随机化后24小时内全因死亡或大量输血复合终点)发生率全血组48.7% vs 标准组47.7%(RR 1.02,95%CI 0.80-1.31,P=0.84)。全因死亡、大量输血及其他次要结局在两组间似乎相似;凝血酶原时间高于正常范围者全血组40.7% vs 标准组30.5%;标准组严重不良事件多于全血组(分别为37和31起);血栓事件发生率两组似乎相似。

要点

  • 严重创伤性出血患者院前输注最多2单位全血,24小时内死亡或大量输血复合终点48.7% vs 标准成分血治疗47.7%(RR 1.02,95%CI 0.80-1.31,P=0.84),未达优效。
  • 全因死亡(所有时间点)、大量输血及其他次要结局在两组间似乎相似。
  • 凝血酶原时间高于正常范围者全血组40.7% vs 标准组30.5%。
  • 严重不良事件标准组37起 vs 全血组31起;血栓事件发生率两组似乎相似。
  • 该试验为实用性、3期、多中心、非盲、随机、优效性设计,在英格兰10家空中救护服务机构开展。

适用人群与场景

  • 由参与试验的空中救护服务机构接诊的重大创伤性出血患者,随机化后排除非创伤性出血或创伤性心脏骤停者纳入分析(全血组314例,标准组302例)。

处置流程与药物剂量

  • 随机分配至院前全血输注(最多2单位)或标准成分血治疗(最多2单位红细胞和2单位血浆),均于到达医院前给予。

研究设计与关键结果

  • 实用性、3期、多中心、非盲、随机、优效性试验,在英格兰10家空中救护服务机构开展,942例随机化,616例纳入分析(全血组314例,标准组302例)。
  • 主要终点(随机化后24小时内全因死亡或大量输血[≥10单位血液成分或制品]复合终点)发生率全血组48.7% vs 标准组47.7%(RR 1.02,95%CI 0.80-1.31,P=0.84)。
  • 全因死亡(所有时间点)、大量输血及其他次要结局在两组间似乎相似。
  • 凝血酶原时间高于正常范围者全血组40.7% vs 标准组30.5%。
  • 严重不良事件标准组37起 vs 全血组31起;血栓事件发生率两组似乎相似。

证据类型、等级与局限

  • 证据类型:实用性、3期、多中心、非盲、随机、优效性试验(ISRCTN23657907)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在危及生命的出血患者中,院前输注2单位全血在降低24小时内死亡或大量输血风险方面不优于标准成分血治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking.

METHODS: We conducted a pragmatic, phase 3, multicenter, unblinded, randomized, superiority trial across 10 air ambulance services in England. Patients with major traumatic hemorrhage who were attended by a participating air ambulance service were randomly assigned to receive either whole-blood transfusion (up to 2 units) or standard care with blood components (up to 2 units each of red cells and plasma) before arrival at the hospital. The primary outcome was a composite of death from any cause or massive transfusion (≥10 units of blood components or products) within 24 hours after randomization.

RESULTS: A total of 942 patients underwent randomization. After the exclusion of participants with nontraumatic hemorrhage or traumatic cardiac arrest, 616 were included in the analysis (314 in the whole-blood group and 302 in the standard-care group). A primary-outcome event occurred in 48.7% of the participants in the whole-blood group and in 47.7% of those in the standard-care group (relative risk, 1.02; 95% confidence interval, 0.80 to 1.31; P = 0.84). The incidence of death from any cause at all time points, massive transfusion, and other secondary outcomes appeared to be similar in the two groups. Prothrombin times were above the normal range in 40.7% of the participants in the whole-blood group and in 30.5% of those in the standard-care group. More serious adverse events occurred in the standard-care group than in the whole-blood group (37 and 31, respectively). The incidence of thrombotic events appeared to be similar in the two groups.

CONCLUSIONS: Among participants with life-threatening hemorrhage, prehospital transfusion of 2 units of whole blood was not superior to standard care in reducing the risk of death or massive transfusion within 24 hours. (Funded by NHS Blood and Transplant and others; ISRCTN Registry number, ISRCTN23657907.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Smith JE, Cardigan R, Sanderson E, et al. Prehospital Whole Blood in Traumatic Hemorrhage - A Randomized Controlled Trial. N Engl J Med. 2026. PMID: 41841706. doi:10.1056/NEJMoa2516043

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。